QI
CYTK icon

Quotient Investors’s Cytokinetics CYTK Stock Holding History

Quotient Investors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,800
Closed -$100K – 256
2015
Q1 		$100K Sell
14,800
-15,200
-51% -$114K 0.01% 235
2014
Q4 		$240K Sell
30,000
-7,400
-20% -$31.8K 0.05% 213
2014
Q3 		$132K Hold
37,400
– – 0.03% 227
2014
Q2 		$179K Buy
37,400
+15,900
+74% +$97K 0.04% 235
2014
Q1 		$204K Buy
+21,500
New +$194K 0.05% 217

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Quotient Investors's CYTK Position: Q2 2015 in Review

Quotient Investors sold out of Cytokinetics (CYTK) in Q2 2015, closing a stake of 14,800 shares — an estimated $100K sold.

Quotient Investors first reported a position in CYTK in Q1 2014 and held it in 5 quarters. The position peaked at $240K in Q4 2014. 99 funds tracked by Wall St. Rank hold CYTK as of Q2 2015.

  • Quotient Investors reported no remaining Cytokinetics position as of Q2 2015 after selling out during the quarter.
  • Quotient Investors sold 14,800 Cytokinetics shares in Q2 2015, an estimated $100K.
  • Quotient Investors first reported a position in Cytokinetics in Q1 2014 and held it in 5 quarters.
  • Quotient Investors's Cytokinetics position peaked at $240K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2015.

Based on Quotient Investors's 13F filing for Q2 2015, filed 16 Jul 2015.